| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |